GU Cancers 2020 | Optimizing immunotherapy duration

Name: Optimizing immunotherapy duration
Uploaded: 2020-02-15T09:00:34Z
Description: Hans Hammers, MD, PhD, The University of Texas Southwestern, Dallas, TX, discusses the importance of individualized approaches to determine the best duration of immunotherapy treatment. Specifically, he focuses on the need to optimize patient outcomes and reducing unnecessary costs. This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.

Hans Hammers • 15 Feb 2020

GU Cancers 2020

General Antibodies Checkpoint Inhibitors

Hans Hammers, MD, PhD, The University of Texas Southwestern, Dallas, TX, discusses the importance of individualized approaches to determine the best duration of immunotherapy treatment. Specifically, he focuses on the need to optimize patient outcomes and reducing unnecessary costs. This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.